Asset Publisher

Drug Withdrawal

Drug Withdrawal

Drug Withdrawal

3/3/2016

The Ministry of Health (MOH) represented by the Directorate General of Pharmaceutical Affairs and Drug Control issued a circular to withdraw three batches of the product 400 mg Omafen tablets (No: 0514005, 0513011, 0515006) manufactured by the National Pharmaceutical Industries Company.

The active ingredient of this drug is Ibuprofen which is used as a painkiller (analgesic), antipyretic, and anti-inflammatory.

The drug has been withdrawal due to a physical defect in the three mentioned batches. Taken into consideration that the other batches of the same drug are available and marketed in the Sultanate, as well as not affected by this decision.



Comments